Menu Search
Equities

Ontrak Inc

HY10:DUS

Ontrak Inc

Actions
  • Price (EUR)0.1772
  • Today's Change-2.48 / -93.33%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 08:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Ontrak, Inc. is an artificial intelligence (AI) and telehealth-enabled healthcare company. The Company identifies, engages, activates, and provides care pathways to treatment for the most vulnerable members of the behavioral health population who would otherwise fall through the cracks of the healthcare system. It engages individuals with anxiety, depression, substance-use disorders and chronic disease through personalized care coaching and customized care pathways that help them receive the treatment and advocacy they need, despite the socio-economic, medical and health system barriers that exacerbate the severity of their comorbid illnesses. Its technology-enabled platform utilizes claim-based analytics and predictive modeling to provide analytic insights throughout the delivery of its personalized care program. The Company integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaches.

  • Revenue in USD (TTM)12.39m
  • Net income in USD-36.52m
  • Incorporated2003
  • Employees102.00
  • Location
    Ontrak Inc333 S. E. 2ND AVENUE, SUITE 2000MIAMI 33131United StatesUSA
  • Phone+1 (310) 444-4300
  • Fax+1 (310) 444-5300
  • Websitehttps://ontrakhealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.